VN1R34P

Across TCGA pan-cancer cohorts, VN1R34P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of VN1R34P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where VN1R34P RNA is repressed in tumor relative to normal tissue. In most cancer types VN1R34P is over-expressed in tumor, although a few such as THCA and HNSC show the opposite, repressed pattern.

THCA, HNSC, and COAD are the cancer types where VN1R34P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R34P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	IV	−0.142	.002	5	view →
HNSC	All	II,III,IV	−0.009	.022	2	view →
COAD	All	All	+0.042	.044	1	view →
LUSC	Male	All	−0.020	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

VN1R34P–THCA

Open the THCA breakdown →